Department of Obstetrics and Gynecology, Northwell Health at South Shore University Hospital (Drs Lu, Lin, Demertzis, Muscat, Fest, and McCue), Bay Shore, NY.
Biostatistics Unit, Office of Academic Affairs, Northwell Health (Ms Shahani), Manhasset, NY.
Am J Obstet Gynecol MFM. 2024 Apr;6(4):101318. doi: 10.1016/j.ajogmf.2024.101318. Epub 2024 Feb 28.
Outpatient term preinduction cervical ripening with mechanical agents has been associated with reduced length of stay, decreased cesarean delivery rates, low maternal and neonatal complications, and increased incidence of vaginal delivery within 24 hours.
This study aimed to demonstrate equivalent efficacy between synthetic hygroscopic dilators and the single-balloon catheter for outpatient cervical ripening.
This randomized control equivalence trial compared synthetic hygroscopic dilators with the 30-mL silicone single-balloon catheter in primiparous and multiparous patients undergoing labor induction. The primary outcome was time from admission to delivery, with a prespecified 3-hour margin of equivalence. The secondary objectives were patient outcomes and perspectives.
Between March 1, 2019, and May 31, 2021, 1605 patients met the screening criteria, and 174 patients completed the study. The mean admission-to-delivery time was equivalent at 18.01 hours for the dilator group vs 17.55 hours for the balloon group (P=.04). The cesarean delivery rate of primiparous patients was similar at 28.1% with dilators vs 29.7% with the balloon. The groups had similar median cervical dilation and pain scores on insertion and admission. Overall patient satisfaction was high, 92.8% with dilators vs 96.2% with the balloon. The balloon group had significantly higher rates of early admission and device expulsion.
Although the enrollment goal was not met, our study suggests that synthetic hygroscopic dilators and the single-balloon catheter for outpatient cervical ripening are both efficacious with similar time from admission to delivery, pain scores, and patient satisfaction with the procedure.
门诊经机械方法进行的产前宫颈成熟可减少住院时间、降低剖宫产率、降低母婴并发症发生率,并增加 24 小时内阴道分娩的发生率。
本研究旨在证明合成吸湿扩张器与单球囊导管在门诊宫颈成熟中的等效疗效。
这项随机对照等效试验比较了初产妇和经产妇使用合成吸湿扩张器与 30 毫升硅胶单球囊导管进行分娩诱导的情况。主要结局是从入院到分娩的时间,预设了 3 小时的等效差距。次要目标是患者结局和观点。
2019 年 3 月 1 日至 2021 年 5 月 31 日,共有 1605 名患者符合筛选标准,其中 174 名患者完成了研究。扩张器组的平均入院至分娩时间为 18.01 小时,与球囊组的 17.55 小时相当(P=.04)。初产妇的剖宫产率相似,扩张器组为 28.1%,球囊组为 29.7%。两组在插入和入院时的宫颈扩张和疼痛评分中位数相似。总体患者满意度高,扩张器组为 92.8%,球囊组为 96.2%。球囊组的早期入院和器械脱落率明显较高。
尽管未达到入组目标,但本研究表明,合成吸湿扩张器和单球囊导管用于门诊宫颈成熟均有效,入院至分娩时间、疼痛评分和患者对该过程的满意度相似。